Your browser doesn't support javascript.
loading
Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening.
Steponaviciene, Laura; Vincerzevskiene, Ieva; Briediene, Ruta; Urbonas, Vincas; Vanseviciute-Petkeviciene, Rasa; Smailyte, Giedre.
Afiliação
  • Steponaviciene L; Laboratory of Cancer Epidemiology, National Cancer Institute, Vilnius, Lithuania.
  • Vincerzevskiene I; Department of Public Health, Institute of Health Sciences of the Faculty of Medicine of Vilnius University, Lithuania.
  • Briediene R; Laboratory of Cancer Epidemiology, National Cancer Institute, Vilnius, Lithuania.
  • Urbonas V; Department of Radiology, National Cancer Institute, Vilnius, Lithuania.
  • Vanseviciute-Petkeviciene R; Department of Radiology, Medical Physics and Nuclear Medicine, Vilnius University, Vilnius, Lithuania.
  • Smailyte G; Laboratory of Clinical Oncology, National Cancer Institute, Vilnius, Lithuania.
Cancer Control ; 26(1): 1073274819874122, 2019.
Article em En | MEDLINE | ID: mdl-31502471
OBJECTIVE: Analysis of interval cancers is critical in determining the sensitivity of screening and represents an objective measure of the quality of mammography screening program (MSP). METHODS: Period analyzed: from 2006 to 2012. The rate of screen-detected, interval cancers and program sensitivity were measured. A comparison of screen-detected and interval cancers was performed. RESULTS: During the period of the study, 429 473 women were screened and 1297 were found to have cancer. The overall screen-detected cancer rate was 30.2 per 10 000 women screened. Four hundred thirty-one case of interval cancers have occurred during the period of the study. The interval cancer ratio (ICR) was 0.25. Overall sensitivity of MSP amounted to 75.1%. Slightly lower sensitivity was found among the youngest age-group, especially for those with lobular cancers. Interval cancers were bigger in size, more often with metastases in lymph nodes, than screen-detected cancers, but these differences were not statistically significant. CONCLUSIONS: Overall program sensitivity in Lithuania is about 75%, ICR is 0.25, and these parameters are comparable to other European countries.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamografia / Programas de Rastreamento / Detecção Precoce de Câncer Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Aged / Female / Humans / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamografia / Programas de Rastreamento / Detecção Precoce de Câncer Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Aged / Female / Humans / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article